Replies to post #18128 on Ayala Pharmaceuticals Inc (fka ADXS)

[gajj]

part of the problem has been abysmal PR by Advaxis. Look how many times our PR people have changed in the past few years.

[Crcook]

Actually, to me it seems obvious that the shorts/manipulators etc. are having their way with ADXS because of the extended timeline regarding the current Phase 3 which is as an adjuvant not even first line......so, basically any short term catalyst will be essentially a binary event coming from unknown source/event and unknown timing. So basically, place your bet and spin the wheel....it will be black or red.....EMA approval, combo with Merck, combo with Astra, etc, etc. EU partner, etc, etc.

with binary events, the results can go your way or the other way----no way to know in advance. With clinical stage bio's the odds are against so the short thesis is the results will be bad but even if not they will take their chance covering at news of the event or shortly after when the manipulators try to short it back down. Time alone will tell who the winners or losers will be.
I will keep my 75,000 shares/warrants bet on success.

GLTAL's

[raja48185]

Sad part is the company went from being ahead in the game to laggards, even as they raised capital and nothing much has happened - at least till now and seems to be so for the rest of 2017, based on the company's own outlook for 2017.

Misplaced priorities, trying to do too much at a time - as if this were a BP, and who knows what missteps management has taken over these years, have affected the stock price, the confidence of investors and the health of the company.

This is no longer a baby biotech in terms of years in being in business. More like a old dog that has lost its teeth and some bite.

[oakrock]

"Waiting Periods" are fodder for Shorts....They will get caught soon enough... They are gambling. The big news bomb drop will get them and they will not know what hit them.